German intensive care physician expect in the face of rising Sars-CoV-2 infections need to be a significant increase in the number of patients treated in intensive care and ventilated. “We have more infections, it takes a certain time until some of these new infections are among be ill,” said Gernot Marx, Chairman of the working group intensive care medicine of the German society for anesthesia and intensive care medicine, the F. A. Z.
Rüdiger, they
Political correspondent in the state of Baden-Württemberg.
F. A. Z.
On 11. April had reported to the Robert Koch-Institute 57.714 acute Sars-CoV-2 infection cases; on 18. April treated in German hospitals 2922 Covid-19-patients in intensive care, of which 2180 were ventilated. Following this peak, Numbers decreased. “We are prepared, we have learned from the first wave. We can drive the capacity for ventilator dependent patients quickly,“ says Marx. You’ve learned, the Director of the clinic for intensive medicine at the Aachen University hospital, the corticosteroid drug dexamethasone to reduce mortality from Covid-19-patients and the drug Remdesivir could shorten the course of the disease. But: “The disease for younger, healthy people are dangerous.” A study showed that 28 percent of ventilated patients who died were younger than 60 years.
in mid-June, had a lot of hospitals no Covid-19-patients more; now you can observe a slight increase. On 6.August, the Germans treated in hospitals in intensive care units 236 Covid-19-patients, 131 were non-invasively ventilated.
